Technical Analysis for MTP - Midatech Pharma PLC

Grade Last Price % Change Price Change
grade F 0.15 -3.23% -0.01
MTP closed down 3.23 percent on Friday, January 18, 2019, on 79 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MTP trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Resistance Bearish 0.00%
Jan 18 180 Bearish Setup Bearish Swing Setup 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Oversold Stochastic Weakness 0.00%
Jan 17 Narrow Range Bar Range Contraction -3.23%
Jan 17 NR7 Range Contraction -3.23%
Jan 17 Stochastic Reached Oversold Weakness -3.23%
Jan 17 Inside Day Range Contraction -3.23%
Jan 17 Wide Bands Range Expansion -3.23%
Jan 17 Oversold Stochastic Weakness -3.23%

Older signals for MTP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
Midatech Pharma Plc engages in the discovery and development of pharmaceutical products in the field of nanomedicine. It develops therapeutic products to enhance the delivery of medicines in diseases, which include diabetes and neurological/ophthalmologic conditions, as well as cancers, such as liver and pancreatic, ovarian, and brain. The company was founded in 2000 and is based in Abingdon, the United Kingdom.
Is MTP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 2 Small med firms see increased buying
Dec 21 The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Dec 12 The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel
Dec 11 The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings
Dec 11 Here’s What Münchener Tierpark Hellabrunn AG’s (MUN:MTP) P/E Is Telling Us
Nov 29 The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved
Nov 28 The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings
Oct 10 Why Münchener Tierpark Hellabrunn AG (MUN:MTP) Delivered An Inferior ROE Compared To The Industry
Oct 3 MTP: Converting to R&D Focused Company Through Divestiture of U.S. Commercial Arm…
See more MTP news...
Indicators
Indicator Value
52 Week High 1.8
52 Week Low 0.1233
Average Volume 297,387
200-Day Moving Average 0.5688
50-Day Moving Average 0.2361
20-Day Moving Average 0.1619
10-Day Moving Average 0.1715
Average True Range 0.03
ADX 17.33
+DI 23.2763
-DI 19.4484
Chandelier Exit (Long, 3 ATRs ) 0.15
Chandelier Exit (Short, 3 ATRs ) 0.2133
Upper Bollinger Band 0.2003
Lower Bollinger Band 0.1235
Percent B (%b) 0.35
BandWidth 47.436689
MACD Line -0.0204
MACD Signal Line -0.025
MACD Histogram 0.0047
Fundamentals Value
Market Cap 3.65 Million
Num Shares 24.4 Million
EPS -1.27
Price-to-Earnings (P/E) Ratio -0.12
Price-to-Sales 3.68
Price-to-Book 0.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.18
Resistance 3 (R3) 0.18 0.18 0.18
Resistance 2 (R2) 0.18 0.17 0.18 0.17
Resistance 1 (R1) 0.16 0.16 0.16 0.16 0.17
Pivot Point 0.16 0.16 0.16 0.16 0.16
Support 1 (S1) 0.14 0.15 0.14 0.14 0.13
Support 2 (S2) 0.14 0.14 0.14 0.13
Support 3 (S3) 0.12 0.14 0.13
Support 4 (S4) 0.12